Corbus Pharmaceuticals Holdings Inc at JPMorgan Healthcare Conference Transcript
Good morning, everyone. Welcome. We're excited to be continuing our 44th Annual JPMorgan Healthcare Conference. My name is Roland Ye. I'm associate on the health care investment banking team.
And today, it's my pleasure to introduce Corbus Pharmaceuticals and CEO, Yuval Cohen. We'll have time for Q&A at the end. And with that, we'll hand it over to Yuval.
Good morning, everyone. Roland, thank you so much for that introduction. It's a delight to be here. We're very grateful to the JPMorgan team for hosting us again. I'm going to focus this morning on two of our assets.
I'll start with important milestones coming up this year for our ADC. And then I'll talk a bit more about a refresher of our recent obesity data and the milestone there. I'm assuming everyone in this room and probably everyone listening knows the background of Corbus, understands our pipeline. So let's dive straight into it.
The key
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
